A BBB disrupter is also a potent alpha-Synuclein aggregation Inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson's disease

D. Segal, R. Shaltiel-Karyo, M. Frenkel-Pinter, E. Rockenstein, C. Patrick, M. Levy-Sakin, N. Egoz-Matia, E. Masliah, E. Gazit

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S108-S109
JournalJournal of Molecular Neuroscience
StatePublished - Nov 2013

Cite this